Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of$ 0.27. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this medical device company focused on psychiatric disorders would post a loss of$ 0.33 per share when it actually produced a loss of $0.27, delivering a surprise of 18.18%. Over t ...